Table 4.
Panel | Relative Set Name | Absolute Set Name | P-Value |
---|---|---|---|
CD31 | ++++.+-+ | CD29+CD31+CD56+CXCR4+CD90+Sca1-CD44+ | 0.027 |
CD31 | ++++.+-. | CD29+CD31+CD56+CXCR4+CD90+Sca1- | 0.027 |
CD31 | ++.+-+-+ | CD29+CD31+CXCR4+CD105-CD90+Sca1-CD44+ | 0.036 |
CD31 | ++.+-+-. | CD29+CD31+CXCR4+CD105-CD90+Sca1- | 0.036 |
CD31 | ++.+-.-+ | CD29+CD31+CXCR4+CD105-Sca1-CD44+ | 0.027 |
CD31 | ++.+-.-. | CD29+CD31+CXCR4+CD105-Sca1- | 0.028 |
CD31 | ++.+.+-+ | CD29+CD31+CXCR4+CD90+Sca1-CD44+ | 0.027 |
CD31 | ++.+.+-. | CD29+CD31+CXCR4+CD90+Sca1- | 0.027 |
CD31 | ++.+.+.+ | CD29+CD31+CXCR4+CD90+CD44+ | 0.02 |
CD31 | ++.+.+.. | CD29+CD31+CXCR4+CD90+ | 0.02 |
CD31 | +-++---. | CD29+CD31-CD56+CXCR4+CD105-CD90-Sca1- | 0.027 |
CD31 | +.++-+-+ | CD29+CD56+CXCR4+CD105-CD90+Sca1-CD44+ | 0.02 |
CD31 | +.++-+-. | CD29+CD56+CXCR4+CD105-CD90+Sca1- | 0.02 |
CD31 | +.++-+.+ | CD29+CD56+CXCR4+CD105-CD90+CD44+ | 0.02 |
CD31 | +.++-+.. | CD29+CD56+CXCR4+CD105-CD90+ | 0.02 |
CD31 | +.++.+-+ | CD29+CD56+CXCR4+CD90+Sca1-CD44+ | 0.02 |
CD31 | +.++.+-. | CD29+CD56+CXCR4+CD90+Sca1- | 0.02 |
CD31 | +.++.+.+ | CD29+CD56+CXCR4+CD90+CD44+ | 0.02 |
CD31 | +.++.+.. | CD29+CD56+CXCR4+CD90+ | 0.02 |
CD31 | +..+-+.+ | CD29+CXCR4+CD105-CD90+CD44+ | 0.014 |
CD31 | +..+-+.. | CD29+CXCR4+CD105-CD90+ | 0.014 |
CD31 | +..+.+.+ | CD29+CXCR4+CD90+CD44+ | 0.014 |
CD31 | +..+.+.. | CD29+CXCR4+CD90+ | 0.014 |
Relative set name, absolute set name, and p-value (Wilcoxon rank sum, one-sided) are shown. P-values are calculated excluding data for one outlier control animal. These are also sets in which at least 6 of 8 wounded animals show average delta readouts greater than the process control range.